CO-DIAGNOSTICS RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHMon, 06 Apr 2026 11:06:54 +0200https://images.finanzen.net/images/finanzen_net_neu.gifCO-DIAGNOSTICS RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netCo-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor RelationshipsMon, 12 Jan 2026 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/co-diagnostics-jv-cosara-participates-in-regional-conferences-to-grow-and-strengthen-distributor-relationships-15409294

SALT LAKE CITY, Jan. 12, 2026 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/co-diagnostics-jv-cosara-participates-in-regional-conferences-to-grow-and-strengthen-distributor-relationships-15409294Co-Diagnostics Announces Reverse Stock SplitTue, 30 Dec 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/co-diagnostics-announces-reverse-stock-split-15384881

SALT LAKE CITY, Dec. 30, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/co-diagnostics-announces-reverse-stock-split-15384881Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform TechnologiesMon, 29 Dec 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/co-diagnostics-receives-grant-of-australian-patent-covering-co-dx-pcr-platform-technologies-15382854

The Australian patent represents the first patent granted for the Company's new point-of-care testing platform

SALT ...

]]>https://www.finanzen.net/nachricht/aktien/co-diagnostics-receives-grant-of-australian-patent-covering-co-dx-pcr-platform-technologies-15382854Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, IndiaThu, 18 Dec 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/co-diagnostics-joint-venture-cosara-invited-to-participate-in-2nd-advanced-tb-diagnostics-course-in-chennai-india-15368327

SALT LAKE CITY, Dec. 18, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/co-diagnostics-joint-venture-cosara-invited-to-participate-in-2nd-advanced-tb-diagnostics-course-in-chennai-india-15368327Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 MutationWed, 17 Dec 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/co-diagnostics-performs-analysis-of-influenza-co-primers-to-confirm-reactivity-against-flu-a-h3n2-mutation-15365184

SALT LAKE CITY, Dec. 17, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the ...

]]>https://www.finanzen.net/nachricht/aktien/co-diagnostics-performs-analysis-of-influenza-co-primers-to-confirm-reactivity-against-flu-a-h3n2-mutation-15365184Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025Tue, 09 Dec 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/co-diagnostics-to-present-on-co-dx-pcr-platform-and-ai-integration-at-point-of-care-testing-2025-15345968

SALT LAKE CITY, Dec. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the ...

]]>https://www.finanzen.net/nachricht/aktien/co-diagnostics-to-present-on-co-dx-pcr-platform-and-ai-integration-at-point-of-care-testing-2025-15345968Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, IndiaMon, 08 Dec 2025 18:36:00 +0100https://www.finanzen.net/nachricht/aktien/co-diagnostics-jv-cosara-to-participate-at-virocon-2025-in-pune-india-15343633

Ongoing Phase II preclinical study data for Co-Dx PCR MTB and HPV tests support advancement to clinical performance testing

]]>https://www.finanzen.net/nachricht/aktien/co-diagnostics-jv-cosara-to-participate-at-virocon-2025-in-pune-india-15343633Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung HealthThu, 20 Nov 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/co-diagnostics-delivers-address-about-tuberculosis-test-adoption-and-implementation-at-the-union-world-conference-on-lung-health-15295655

SALT LAKE CITY, Nov. 20, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" ...

]]>https://www.finanzen.net/nachricht/aktien/co-diagnostics-delivers-address-about-tuberculosis-test-adoption-and-implementation-at-the-union-world-conference-on-lung-health-15295655Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDATue, 18 Nov 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/co-diagnostics-initiates-clinical-evaluations-for-upper-respiratory-multiplex-point-of-care-test-on-co-dx-pcr-platform-to-support-submission-to-the-u-s-fda-15288116

SALT LAKE CITY, Nov. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" ...

]]>https://www.finanzen.net/nachricht/aktien/co-diagnostics-initiates-clinical-evaluations-for-upper-respiratory-multiplex-point-of-care-test-on-co-dx-pcr-platform-to-support-submission-to-the-u-s-fda-15288116Co-Diagnostics stellte Zahlen zum jüngsten Quartal vorSat, 15 Nov 2025 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/co-diagnostics-stellte-zahlen-zum-juengsten-quartal-vor-15278888Co-Diagnostics hat am 13.11.2025 die Bücher zum am 30.09.2025 abgelaufenen Quartal geöffnet.Dabei wurde ein Verlust je Aktie von 0,16 USD ausgewiesen. Im Vorjahresquartal waren -0,320 USD je Aktie erwirtschaftet ...

]]>https://www.finanzen.net/nachricht/aktien/co-diagnostics-stellte-zahlen-zum-juengsten-quartal-vor-15278888